Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephroprotection by antihypertensive therapy

J Jacobi1, R E Schmieder

  • 1Medizinische Klinik IV/4, University of Erlangen-Nürnberg, Germany.

Basic Research in Cardiology
|December 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.

Cardiovascular diabetology·2021
Same author

Sildenafil Protects Endothelial Cells From Radiation-Induced Oxidative Stress.

The journal of sexual medicine·2019
Same author

[Comments on the guidelines (2018) of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) on the management of arterial hypertension].

Der Internist·2019
Same author

First Report of Bacterial Gall on Loropetalum chinense Caused by Pseudomonas savastanoi in the United States.

Plant disease·2019
Same author

[European guidelines for the management of arterial hypertension 2018-what has changed?]

Der Internist·2019
Same author

Gastrointestinal: Superinfection of a large cystic mucinous pancreatic neoplasm.

Journal of gastroenterology and hepatology·2018

Controlling high blood pressure is crucial for kidney health. Certain antihypertensive drugs, like ACE inhibitors, offer superior kidney protection beyond just lowering blood pressure.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • End-stage renal failure poses a significant health burden.
  • Arterial hypertension is a primary risk factor for progressive renal disease.
  • Blood pressure control is vital for preserving renal function.

Purpose of the Study:

  • To review the nephroprotective effects of various antihypertensive agents.
  • To highlight the benefits of aggressive blood pressure control in renal patients.
  • To compare the renal outcomes associated with different drug classes.

Main Methods:

  • Literature review of studies on hypertension and chronic kidney disease.
  • Analysis of randomized controlled trials on antihypertensive therapies.
  • Evaluation of hemodynamic and non-hemodynamic effects of drugs on renal function.

Related Experiment Videos

Main Results:

  • Antihypertensive therapy below 140/90 mmHg improves renal survival.
  • ACE inhibitors and calcium channel blockers show specific nephroprotective properties.
  • ACE inhibitors demonstrate superior long-term renal protection compared to other agents.

Conclusions:

  • Aggressive blood pressure management is key for chronic kidney disease patients.
  • ACE inhibitors offer significant nephroprotection, independent of blood pressure reduction.
  • Further research on AT1 receptor antagonists is needed to clarify their role in renal survival.